|Home | About | Journals | Submit | Contact Us | Français|
Animal influenza viruses (AIVs) are a major threat to human health and the source of pandemic influenza. A reliable small-mammal model to study the pathogenesis of infection and for testing vaccines and therapeutics against multiple strains of influenza virus is highly desirable. We show that cotton rats (Sigmodon hispidus) are susceptible to avian and swine influenza viruses. Cotton rats express α2,3-linked sialic acid (SA) and α2,6-linked SA residues in the trachea and α2,6-linked SA residues in the lung parenchyma. Prototypic avian influenza viruses (H3N2, H9N2, and H5N1) and swine-origin 2009 pandemic H1N1 viruses replicated in the nose and in the respiratory tract of cotton rats without prior adaptation and produced strong lung pathology that was characterized by early lung neutrophilia, followed by subsequent pneumonia. Consistent with other natural and animal models of influenza, only the H5N1 virus was lethal for cotton rats. More importantly, we show that the different avian and pandemic H1N1 strains tested are strong activators of the type I interferon (IFN)-inducible MX-1 gene both locally and systemically. Our data indicate that the cotton rat is a suitable small-mammal model to study the infection of animal influenza viruses and for validation of vaccines and therapeutics against these viruses.
The pathogenesis and interspecies transmission of avian- and swine-origin influenza viruses remain major research topics. The 1997 outbreak of H5N1 avian influenza virus, which was transmitted to individuals with close contact with birds, propelled efforts to understand the pathogenesis of human infections with the potential to cause pandemics (1, 2). Additional human infections with H7N7, H7N3, and H9N2 avian influenza viruses in Canada, Europe, and Asia have further highlighted the necessity for the investigation of factors controlling avian influenza virus-host interactions (3–5).
More recently, the emergence of the swine-origin 2009 H1N1 pandemic influenza (H1N1pdm) virus highlighted the need for an improved understanding of the viral and host factors that lead to efficient replication of influenza viruses in new hosts. Since its emergence in Mexico in 2009 (6), H1N1pdm has become established in the human population and appears to have displaced the seasonal H1N1 viruses but not the seasonal H3N2 and influenza B viruses. Although it was perceived as generally mild, approximately 18,000 deaths were attributed to the H1N1pdm during the pandemic period (7). The illness in hospitalized patients with H1N1pdm was associated with an early onset that included fever, cough, pharyngalgia, shortness of breath, headache, myalgia, diarrhea, and vomiting, which progressed to respiratory failure or multiple organ failure in fatal cases (8).
Increasing evidence suggests that the host immune response plays a critical role in determining various outcomes of influenza virus infection (9). The inflammatory response induced during infection may favor viral clearance (10, 11). However, when this response is exacerbated, it may be highly detrimental to the host (12, 13). It is accepted that the high mortality rates seen in infections with highly pathogenic avian influenza viruses are associated with an overactive inflammatory response, and the severity of the disease is closely related to the magnitude of the virus-induced cytokine storm (13).
The mechanism of how animal influenza viruses (AIVs) directly infect humans and other mammals is multifactorial, although it is considered that the viral surface hemagglutinin (HA) protein plays a pivotal role due to its specificity for sialic acid (SA) receptors. Animal models are critical for studies on this mechanism, as findings in animal models are more reflective of these intricacies than those in cell cultures. Receptor specificity and the pattern of expression and distribution of influenza virus SA receptors dictate, at least in part, the fate of influenza virus infection. For example, the airway epithelium of mice, which is a small-animal model of influenza, predominantly express receptors with SA linked to cell surface glycoproteins or glycolipids in an α2,3-linkage (α2,3-linked SA receptors) (14). Most human influenza viruses preferentially bind α2,6-linked SA receptors. Thus, it is not surprising that the majority of human influenza viruses require prior adaptation before being able to replicate efficiently in the mouse.
The cotton rat (Sigmodon hispidus) has been established as a model for influenza research as it is highly permissive for human influenza A and B viruses without prior adaptation (15, 16). It has been shown that viral titers in nasal and lung tissues in cotton rats infected with human influenza viruses were proportional to the infectious dose, and this model replicated many respiratory features observed in humans (16). In addition, cotton rats have also been used in evaluation of cross-protective or heterosubtypic immunity (17, 18), vaccines (19), and antiviral treatments against influenza (20). Upon challenge with influenza viruses, cotton rats develop signs of disease that can be evaluated quantitatively, allowing the assessment of pathogenicity and its reduction through treatment. However, these studies have been limited to only human influenza virus strains. In this study, we expanded on the characterization of cotton rats as a potential small-animal model of animal influenza infections.
Young adult (4- to 8-week-old) cotton rats (Sigmodon hispidus) of both genders were obtained from the inbred colony maintained at Sigmovir Bioystems, Inc. (SBI). The animals were housed in large polycarbonate cages and fed a diet of standard rodent chow and water. Cotton rats were seronegative for adventitious respiratory viruses and other common rodent pathogens. All experiments were performed using protocols that followed federal guidelines and were approved by SBI's and University of Maryland School of Veterinary Medicine's Institutional Animal Care and Use Committees (IACUC). Cotton rats were infected intranasally (i.n.) with the various influenza virus strains under isoflurane anesthesia by application of 0.1 ml of virus solution. Animals were sacrificed by carbon dioxide inhalation.
Trachea and lung were freshly collected, embedded in OCT (Sakura Finetek USA Inc., Torrance, CA), and cut into 5-mm-thick sections. After air drying overnight, the sections were rinsed with tap water for 1 h, followed by incubation with 3% H2O2 in methanol for 20 min and fixing with cold acetone for 15 min. Subsequently, the sections were blocked with 1% bovine serum albumin (BSA) in Tris-buffered saline (TBS) for 1 h. For detection of receptors, the sections were incubated with digoxigenin (DIG)-labeled Maackia amurensis agglutinin (MAA) (specific for SAα2,3-gal; Boehringer Mannheim Biochemicals, Germany) or Sambucus nigra agglutinin (SNA) (specific for SAα2,6-gal; Boehringer Mannheim Biochemicals, Germany) in buffer I (TBS containing Mg2+, Mn2+, Ca2, and 1% BSA) for 1 h. After washing with TBS, the sections were incubated with peroxidase-conjugated anti-DIG Fab fragments (Boehringer Mannheim Biochemicals, Germany) in TBS containing 1% BSA for 1 h. After washing with 0.05 M Tris (pH 7.6), the sections were developed in a solution of diaminobenzidine (DAB) (for SAα2,3-gal) or aminoethylcarbazole (AEC) (for SAα2,6-gal) containing 3% H2O2 for 10 min, counterstained with hematoxylin, mounted, and observed under a light microscope. All incubation steps were done at room temperature unless otherwise specified. Photos were taken using SPORT ADVANCED software.
The following low-pathogenic avian influenza viruses were used in this study: influenza A/duck/Hong Kong/375/1975 (H3N2) and A/guinea fowl/Hong Kong/WF10/1999 (H9N2) viruses (here referred to as 375/H3N2 and WF10/H9N2, respectively). These viruses were obtained from the influenza virus repository at St. Jude Children's Hospital, Memphis, TN. The highly pathogenic avian influenza H5N1 (A/Vietnam/1203/2004) virus and the pandemic H1N1 (A/California/04/2009) virus were kindly provided by the Centers for Disease Control and Prevention (CDC), Atlanta, GA. A/Netherland/602/09 (H1N1) virus (21, 22), mouse-adapted A/California/04/2009 (H1N1) virus (ma-ca/04) (22), and human H1N1 (A/Brisbane/59/07) and H3N2 (A/Wuhan/359/95) viruses (16) were previously described. Avian viruses were propagated in 10-day-old embryonated, specific-pathogen-free chicken eggs, and all pandemic and seasonal influenza viruses were propagated in Madin-Darby canine kidney (MDCK) cells. Virus stocks were maintained at −80°C until use. Virus stocks generated in eggs were titrated by 50% egg infectious dose (EID50) to equalize the dose of infection. MDCK cells were maintained in modified Eagle's medium (MEM) containing 5% fetal calf bovine serum.
All viruses from tissue samples were titrated on MDCK cells grown to confluence in 96-well plates by 50% tissue culture infectious dose (TCID50) using HA assay as a readout as described previously (22). All titrations were performed in the presence of tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin (Worthington) at a concentration of 1 μg/ml. The tissues analyzed were lung and nose, which were homogenized in 10 parts (wt/vol) of Earle's modified Eagle's medium supplemented with 0.218 M sucrose, 4.4 mM glutamate, 3.8 mM KH2HPO4, and 7.2 mM K2HPO4 (to stabilize virus during freeze-thawing). After centrifugation, supernatants were removed and stored at −80°C until assayed. The lowest level of detection of this assay was 102.5 TCID50 of influenza virus per gram of lung and nose tissue.
Lung tissue (lingular lobe) was flash-frozen in liquid nitrogen and homogenized in 0.5 ml RLT buffer with β-mercaptoethanol using a TissueLyzer LT (two 5-mm beads per sample, 50 Hz, 2 min) (Qiagen). Lung RNA was isolated using an RNeasy kit (Qiagen, catalog number 74106). Blood (~1 ml) was collected in EDTA-containing tubes and lysed with EL buffer within 1 h of collection, and RNA was isolated using the QIAamp RNA Blood Minikit (Qiagen, catalog number 52304).
Reverse transcription was performed using aQuantiTect reverse transcription kit (Qiagen, catalog number 205314). cDNA was diluted in water to give a ratio of 1 µg RNA of the original RNA per 100 ml final volume. Three microliters of cDNA per reaction was used for real-time PCR using the SYBR green PCR kit (Qiagen catalog number 204057). All reactions were done in duplicates. Primers and conditions for MX-1 were described previously (23). MX-1 mRNA expression was normalized to the β-actin gene as a housekeeping gene using the Pfaffi method. Primers for β-actin in this study were 5′-CCCATTGAACACGGCATTGTC-3′ (forward) and 5′-TGTCACGCACGATTTCCCTCTC-3′ (reverse).
Lungs were dissected with the lower 1/3 of the trachea. They were inflated to their normal volume and immersed in 10% neutral buffered formalin. Lungs were evaluated for four indices of pulmonary inflammatory changes: peribronchiolitis (inflammatory cells clustered around the periphery of small airways), perivasculitis (inflammatory cell infiltration around blood vessels), interstitial pneumonia (inflammatory cell infiltration and thickening of alveoli walls), and alveolitis (cells within the alveolar spaces). Slides were scored blind, with validation of scoring by two pathologists experienced in respiratory viral pathogenesis, on a severity scale of 0 to 4 as previously reported (24).
Viral titers were calculated as arithmetic means ± standard errors for all animals in a group at a given time. Pulmonary scores were expressed as the mean ± standard error for all animals in a group. Differences among groups in weight, temperature, and MX-1 expression were evaluated by Student's t test.
Influenza virus infections are mediated by specific interactions between the viral HA and cell oligosaccharides that contain SA residues. Most avian and equine influenza viruses bind to α2,3-linked SA receptors, whereas human viruses, including the earliest available isolates from the 1957 and 1968 pandemics, bind to α2,6-linked SA receptors (25–27). Cell surface receptors for both human (α2,6) and avian (α2,3) influenza viruses have been described in humans (14, 28–30), pigs (31), chickens (32), and quail and other minor poultry species (33, 34).
Since the cotton rat is susceptible to infection with strains of human influenza virus without prior adaptation (16), the receptor distribution in the upper and lower respiratory tracts was analyzed. By performing lectin-based staining, the trachea and minor airways of cotton rats showed strong reactivity with Maackia amurensis agglutinin (MAA), a lectin with specificity for α2,3-linked SA, and Sambucus nigra agglutinin (SNA), a lectin specific for α2,6-linked SA (Fig. 1). By comparing similar sections stained for either α2,3-linked SA or α2,6-linked SA or β-tubulin (a marker of ciliated epithelial cells), we established that α2,6-linked SA receptors are colocalized with ciliated cells, whereas α2,3-linked SA receptors are more associated with mucin-producing cells in the trachea of cotton rats. In addition, staining of the lung parenchyma showed a consistent staining of type I and type II pneumocytes with α2,6-linked SA receptors, whereas α2,3-linked SA receptors were rarely expressed (Fig. 1, lung). These results indicate that both α2,3-linked and α2,6-linked SA receptors are present in the airways of cotton rats, in contrast to the case for mice, where only α2,6-linked SA receptors predominate in the lung tissue. These results explain the susceptibility of cotton rats to infection with human strains of influenza virus and suggest that the cotton rat is potentially susceptible to infection with avian influenza viruses.
To assess the susceptibility of cotton rats to avian influenza viruses, infections were performed using two low-pathogenic strains, A/duck/Hong Kong/375/1975 (H3N2) and A/guinea fowl/Hong Kong/WF10/1999 virus (H9N2) (here referred to as 375/H3N2 and WF10/H9N2, respectively). Cotton rats were infected with a wide range of 375/H3N2 virus inocula (from 102 to 107 EID50/rat), and virus shedding was analyzed at different days postinfection (dpi). When cotton rats were inoculated i.n. with a dose of 107 EID50, virus was isolated from noses and lungs of all animals at 1 and 2 dpi and from a few animals at 7 dpi (Fig. 2A). Lung and nose titers reached ~5 × 105 and ~104 TCID5050/g of tissue, respectively, at 1 dpi (Fig. 2A). Animals inoculated with the lowest dose of virus (102 EID50) still yielded replicative virus in lungs (detected only at 1 dpi) and noses (detected at 1, 2, and 4 dpi) (data not shown). Strong pathology was detected in the lungs of animals infected with 107 EID50 (Fig. 2B and andC).C). The lung pathology was slightly reduced when a dose of 106 EID50 was used, and there was no detectable pathology in animals infected with 105 EID50 (data not shown). At 1 dpi, all four lung pathological parameters measured, i.e., peribronchiolitis, perivasculitis, interstitial pneumonia, and alveolitis, were dramatically enhanced. These parameters peaked at 4 dpi and remained high through 7 dpi. Signs of inflammation remained detectable at 14 dpi (Fig. 2B). The pathology at 1 dpi was characterized by a rapid increase in exfoliation and degeneration of bronchiolar ciliated epithelial cells (Fig. 2C, panel b). Alveolitis was also present, with infiltration of inflammatory cells (mainly neutrophils and macrophages) of the alveolar space (Fig. 2C, panel e). By 4 dpi, there was consolidation of the pathology, with patches of pneumonia as the result of massive cellular infiltration (Fig. 2C, panels c and f). Animals infected with 107 EID50 showed significant decreases in body weight and temperature at 1 and 2 dpi (Fig. 2D and andEE).
Mx proteins are powerful inhibitors of influenza virus replication and sensitive markers of in vivo expression of type I interferons (IFNs) (35). We have previously characterized MX-1 and MX-2 genes in the cotton rat and corroborated the induction of both genes by type I IFN (23), influenza virus (23), and respiratory syncytial virus (36), as well as the capability of MX-1 to inhibit influenza virus infection (37). To further characterize the pathogenesis of these influenza viruses, we measured the expression of the cotton rat MX-1 gene in lungs and blood samples of infected animals (Fig. 2F). We found that infection was followed by strong induction of MX-1 mRNA in the lung, peaking at 1 and 2 dpi, and in the blood, peaking at 1 dpi. MX-1 expression remained significantly higher than that for the control on day 4 and day 7 in the lung and on day 4 in blood (P < 0.05).
Infection of cotton rats with WF10/H9N2 virus showed a pattern of replication similar to that seen for 375/H3N2 virus. When cotton rats were infected with 107 EID50, nasal replication of WF10/H9N2 peaked at 1 dpi (~7 × 104 TCID50/g tissue) and remained relatively high at 2 dpi (Fig. 3A). Higher titers in the lungs than in the nose were observed also for this virus at 1 and 2 dpi. Infection with decreasing doses of WF10/H9N2 (from 107 to 102 EID50) showed virus in the lung even at the lowest dose of 102 EID50 at 1 dpi and in the nose at doses of 103 EID50 or greater (data not shown). The most characteristic lung pathology features detected during infection of cotton rats with the WF10/99 strain was the strong defoliation of the ciliated epithelia and extravasations of neutrophils into bronchioles at 1 dpi (Fig. 3B and andC,C, panel a). Peak histopathology was detected between 2 and 7 dpi, with strong interstitial pneumonia and alveolitis at 2 dpi and strong peribronchiolitis at day 7 and patches of lesion consolidation (Fig. 3C, panel b). Subtle but significant changes in body weight and temperature were detected in cotton rats infected with the WF10/H9N2 virus. Weight loss and temperature drop were evident at 1 dpi (Fig. 3D and andE).E). Strong induction of MX-1 mRNA was detected in lung tissue and blood samples (Fig. 3F), peaking at 1 dpi and remaining significantly higher until 7 dpi in the lung or until 4 dpi in blood (P < 0.05).
To further test the suitability of the cotton rat model for the study of avian influenza, we tested the replication and associated pathology after infection with A/Vietnam/1203/2004 (H5N1), a highly pathogenic virus isolate from a lethal human case (here referred to as 1203/H5N1). Infection of cotton rats with a high dose of 1203/H5N1 virus (107 EID50) given i.n. caused 100% mortality by 2 dpi (Fig. 4A). When animals were infected with106 EID50, 3 out 4 animals died by 3 dpi, while all animals infected with a dose of 105 EID50 or lower survived (Fig. 4A). Our data are consistent with the notion that in humans, a high dose of virus is required to produce a life-threatening infection (38). Furthermore, we found that cotton rats are highly permissive to H5N1 replication. Viral titers in the lungs of animals infected with as low as 104 EID50 reached >107 TCID50/g and were not very different from viral titers in the noses of animals infected with 104 EID50. The same was true for 1203/H5N1 replication in the nose, although titers reached at this site were in general 1 log TCID50/g lower. Virus was isolated from both lungs and noses of all animals infected with a dose of 105 TCID50/g at 4 dpi. Animals infected with 1203/H5N1 showed evident signs of disease, including hunching and piloerection. In addition, all infected animals showed dramatic weight loss (up to 15%) between 1 and 5 dpi, and hypothermia (>3°C drop in body temperature) at day 1, when infected at doses of 105 and 106 EID50 (Fig. 4C and andD).D). Lung pathology scores of cotton rats infected with the 1203/H5N1 virus were plotted after infection of animals with 105 EID50, since either all or 3 out of 4 animals died before 4 dpi in groups infected with 107 and 106 TCID50, respectively. Lung pathology in these animals was pronounced by 1 dpi and further increased, peaking by day 7 postinfection, in animals infected with 105 EID50 (Fig. 4E). Some of the characteristic features observed included rapid infiltration of the alveolar space by neutrophils (alveolitis) (Fig. 4F, panel b) that subsequently developed into a consolidated pneumonia by 4 dpi (Fig. 4F, panel c). Analysis of lung expression of mRNA for the MX-1 gene showed a peak of expression at 1 to 2 dpi, with levels of induction remaining significant at 7 dpi (P < 0.05). Analysis of the expression of MX-1 in blood samples was dose dependent at 1 dpi, reaching a plateau at a dose of virus of 106 to 107 EID50 (Fig. 4G). The expression of mRNA for MX-1 remained strong at 4 dpi in those surviving animals, with levels of activation of MX-1 mRNA expression close to 20-fold above the levels in uninfected control animals (P < 0.05).
We evaluated the infectivity of the prototype pandemic isolate A/California/07/09 (Ca/07) in the cotton rat using two different doses of inocula, 107 and 106 EID50/animal. Virus was isolated from lung and nose at 1 and 2 dpi at both concentrations of viral inocula, with peak viral titers at 1 dpi in both tissues. No virus was isolated after 4 dpi (Fig. 5A). Peak lung histopathology was seen on day 2 postinfection (Fig. 5B), and its intensity was dose dependent, with stronger pathology seen in the lungs of animals infected with the highest dose of virus (Fig. 5C, panels b and c). Detectable lung pathology was observed out to 14 dpi. Infection of cotton rats with Ca/07 did not cause changes in clinical parameters as detected with avian viruses (i.e., in body weight and temperature) at any dose used for infection (data not shown). However, infection with Ca/07 produced a strong increase in the expression of the MX-1 gene in lung and blood (Fig. 5D), which preceded the peak in histopathology.
To characterize the pathogenesis of pandemic H1N1 isolates further, we measured the expression of cotton rat MX-1 gene expression in lung and blood samples of animals infected with two additional H1N1pdm strains and compared its expression in cotton rats infected with seasonal H1N1 and H3N2 viruses (Fig. 6). Infected animals showed measurable levels of MX-1 expression in the lung that peaked by 1 dpi and decreased by 4 dpi, following the pattern previously observed with seasonal influenza virus strains (Fig. 6A) (23). However, the level of expression of MX-1 in the lungs of animals infected with the H1N1pdm strains surpassed that induced by seasonal H1N1 or H3N2. This increase correlated with a stronger induction of MX-1 expression in blood samples of animals infected with H1N1pdm strains (Fig. 6B). Our data indicate that in cotton rats, H1N1pdm is a more potent inducer of type I IFN than nonpandemic strains. Moreover, the data also suggest that at least the H1N1pdm strains tested in this work, and in contrast to seasonal strains, have the unique ability to induce MX-1 antiviral gene expression that can be detected in blood.
In this work we demonstrated that cotton rats are permissive to infection with 2009 pandemic H1N1 strains of influenza virus and several strains of avian influenza virus. All viruses replicated in the respiratory tract of cotton rats and were able to cause moderate to severe lung pathology. In addition, we observed that infection with H1N1pdm and avian influenza virus strains generated stronger type I IFN expression than that with other circulating human influenza virus strains. The high production of type I IFN was evidenced by the simultaneous induction of expression of MX-1, a sensitive marker of type I IFN (35). Importantly, we have shown that the effect of type I IFN became systemic, as high expression of MX-1 mRNA in blood cells was evidenced in animals infected only with H1N1pdm strains.
We hypothesized that the susceptibility of cotton rats to infection with nonadapted strains of avian and human influenza viruses may reside in their sialic acid distribution within the respiratory tract. Although receptors carrying α2,3- and α2,6-SA linkages are found in humans, their distribution is controversial. Initially, a selective localization of α2,3-linked SA in goblet cells and of α2,6-linked SA in ciliated cells of the epithelia of the trachea was reported (28, 39). Mastrosovich and collaborators have shown contrasting results using differentiated cultures of human tracheobronchial epithelium (29). In this study, we found that the localization of α2,6-linked SA in the cotton rat airway was restricted to ciliated cells, whereas α2,3-linked SA was found in nonciliated cells. Our results suggest that the distribution of receptors in cotton rats is similar to the pattern observed in human trachea by Couceiro et al. (28). In addition, we found that the cotton rat lung stained strongly for α2,6-linked SA but not for α2,3-linked SA. The staining for α2,6-linked SA was confined to the base of type II pneumocytes, with some scattered staining in type I pneumocytes (Fig. 1B). The presence of abundant α2,6-linked SA in lungs and tracheae of cotton rats explains, at least in part, the susceptibility of cotton rats to infection with field influenza virus isolates.
The three avian influenza viruses tested in this study replicated and induced strong pathology in the lungs of infected cotton rats, characterized by defoliation of the ciliated epithelium, alveolitis produced by the infiltration of inflammatory cells, and the final development of pneumonia. These viruses included the low-pathogenicity strains H9N2 and H3N2 and a highly pathogenic strain of H5N1. The replication of the low-pathogenic H9N2 virus was likely facilitated by the abundance of α2,3-linked SA receptors in the cotton rat airway. However, our previous data have indicated that the WF10/H9N2 virus used in this study possesses human-like receptor specificity that favors the binding of the α2,6-linked SA moiety (34). Importantly, the H5N1 virus, which preferentially binds to α2,3-linked SA structures (40), infected cotton rats and induced 100% mortality when inoculated at a high dose. This is similar to what has been observed in the ferret model (41, 42). It also correlates with the lethal outcome of this virus in humans, which has been proposed to be the result of infection with a large viral dose (38). Taken together, our infection studies demonstrated that the cotton rat model can be used in the evaluation of avian influenza viruses of different receptor specificities and virulences.
For all avian viruses tested in this study, peak viral replication coincided with the peak of changes in clinical parameters but preceded the peak of the lung pathology. This has been previously seen also for seasonal influenza virus strains in the cotton rat (16). However, this effect was not seen in H1N1pdm infection, which did not show overt changes in the clinical parameters measured and where the peak in lung pathology coincided with the peak in viral titers. This could reflect a different mechanism of engaging the host innate response by H1N1pdm virus.
Our studies using H1N1pdm strains and comparing them with seasonal human strains of influenza virus show that cotton rats recapitulate some of the features observed in other animal models (mice and ferrets) (22). Type I IFN is produced at the site of the viral infection. It is expected that this type of response would impact the clinical presentation of the disease, and thus our study provides clues as to the effectors of H1N1pdm virulence. In fact, expression of Mx-A, the human counterpart of MX-1 in blood, has been used as marker to differentiate between viral and bacterial infection in febrile children (43, 44). However, at this time, it is not clear how different respiratory viruses (including different human strains of influenza virus) regulate the expression of systemic IFN, since its augmentation in blood has been detected for some (e.g., coxsackievirus, adenovirus, respiratory syncytial virus, and cytomegalovirus) (45) but was not found for others (e.g., rhinovirus) (46). The ability of the cotton rat to serve as an animal model for multiple respiratory viruses will likely be instrumental in defining some of the clinical consequences associated with systemic IFN production during infection with certain influenza virus strains.
In short, our studies provided significant evidence that the cotton rat is a viable mammalian model for evaluation of AIVs, particularly those of public health concern. More isolates of AIV will need to be tested to accumulate knowledge of the pathogenesis, immune response, antiviral treatment, and vaccine efficacy against AIVs in this model. The cotton rat model has been demonstrated to be highly susceptible to infection with many respiratory viruses, including respiratory syncytial virus (24), and recently to human rhinovirus serotype 16 (J. C. G. Blanco and A. Kajon, unpublished results), all of which may be able to coinfect a given individual. Therefore, the cotton rat model could become pivotal to decipher the intricacies of mixed respiratory infections.
We are indebted to Gregory Prince for his guidance. We thank Marina Boukhvalova for her suggestions throughout this work. We thank Charles Smith and Freddy and Ana Rivera for their excellent assistance with animal husbandry and Andrea Ferrero for assistance in the biosafety level 3 (BSL3) facility at the University of Maryland, College Park.
This work was supported by Virion Systems, Inc., and Sigmovir Biosystems, Inc., corporate funds to J.C.G.B. and by NIAID contract HHSN266200700010C and CDC-HHS 1U01CI000355-01 to D.R.P.
J.C.G.B. is President of Sigmovir Biosystems, Inc., a basic and contract research organization that uses the cotton rat as an animal model for the study of respiratory viruses.
Published ahead of print 28 November 2012